MedTrace Logo

Tele-Supervised Dual-Task Balance Training in Community-Dwelling Older Adults at Risk of Falls

NCT07557667 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-04-29

No results posted yet for this study

Summary

Dual-task training combines movement with cognitive tasks to improve gait, balance, and thinking.

This study will compare tele-supervised versus onsite dual-task balance training in older adults at risk of falls.

Sixty participants aged 65+ will be randomly assigned to either remote or face-to-face training for 8 weeks.

Both groups will follow the same program, delivered via video calls or direct supervision.

Outcomes measures will include gait speed, balance, and cognition using the 10-Meter Walk Test (10MWT), Berg Balance Scale (BBS), and Trail Making Test Part B (TMT-B).

Conditions

  • Telerehabilitation
  • Gait Balance

Interventions

OTHER

Dual-task balance training program, delivered either via real-time video conferencing

The tele-supervised group will perform sessions at home through Zoom Video Communications. Training will follow a fixed-priority strategy. Sessions will last 45 minutes. Each session will include: 5 minutes warm-up, 35 minutes dual-task training, and 5 minutes cool-down.

OTHER

Face to face intervension

The onsite group received the same dual-task balance training program, delivered face-to-face by a trained therapist at the physical therapy clinic, College of Applied Medical Sciences, Prince Sattam bin Abdulaziz University, with a frequency and duration matched to the tele-supervised group.

Sponsors & Collaborators

  • Prince Sattam Bin Abdulaziz University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-10
Primary Completion
2027-01-10
Completion
2027-02-10

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07557667 on ClinicalTrials.gov